135 related articles for article (PubMed ID: 38048225)
1. The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent.
Middelburg J; Ghaffari S; Schoufour TAW; Sluijter M; Schaap G; Göynük B; Sala BM; Al-Tamimi L; Scheeren F; Franken KLMC; Akkermans JJLL; Cabukusta B; Joosten SA; Derksen I; Neefjes J; van der Burg SH; Achour A; Wijdeven RHM; Weidanz J; van Hall T
Cell Rep; 2023 Dec; 42(12):113516. PubMed ID: 38048225
[TBL] [Abstract][Full Text] [Related]
2. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
[TBL] [Abstract][Full Text] [Related]
3. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
[TBL] [Abstract][Full Text] [Related]
4. A Single-Domain TCR-like Antibody Selective for the Qa-1
Ghaffari S; Upchurch-Ange K; Gimlin S; Tripathi T; Sluijter M; Middelburg J; van Hall T; Weidanz J
J Immunol; 2022 May; 208(9):2246-2255. PubMed ID: 35418467
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.
Kraft JR; Vance RE; Pohl J; Martin AM; Raulet DH; Jensen PE
J Exp Med; 2000 Sep; 192(5):613-24. PubMed ID: 10974028
[TBL] [Abstract][Full Text] [Related]
6. NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E.
Battin C; Kaufmann G; Leitner J; Tobias J; Wiedermann U; Rölle A; Meyer M; Momburg F; Steinberger P
Immunology; 2022 Aug; 166(4):507-521. PubMed ID: 35596615
[TBL] [Abstract][Full Text] [Related]
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
8. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
[TBL] [Abstract][Full Text] [Related]
9. Evidence of functional Cd94 polymorphism in a free-living house mouse population.
Knutsen LE; Dissen E; Saether PC; Bjørnsen EG; Piálek J; Storset AK; Boysen P
Immunogenetics; 2019 Apr; 71(4):321-333. PubMed ID: 30535636
[TBL] [Abstract][Full Text] [Related]
10. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
11. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
Vance RE; Kraft JR; Altman JD; Jensen PE; Raulet DH
J Exp Med; 1998 Nov; 188(10):1841-8. PubMed ID: 9815261
[TBL] [Abstract][Full Text] [Related]
12. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
Cheent KS; Jamil KM; Cassidy S; Liu M; Mbiribindi B; Mulder A; Claas FH; Purbhoo MA; Khakoo SI
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16981-6. PubMed ID: 24082146
[TBL] [Abstract][Full Text] [Related]
14. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
[TBL] [Abstract][Full Text] [Related]
15. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
[TBL] [Abstract][Full Text] [Related]
16. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
[TBL] [Abstract][Full Text] [Related]
17. NK cells: tuned by peptide?
Das J; Khakoo SI
Immunol Rev; 2015 Sep; 267(1):214-27. PubMed ID: 26284480
[TBL] [Abstract][Full Text] [Related]
18. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
19. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
[TBL] [Abstract][Full Text] [Related]
20. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Kamiya T; Seow SV; Wong D; Robinson M; Campana D
J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
